Related Experiment Video
Updated: Feb 18, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
The Role of Genetic Counseling in Pompe Disease After Patients Are Identified Through Newborn Screening
Andrea M Atherton1, Debra Day-Salvatore2,
1Children's Mercy Hospital, Kansas City, Missouri; and.
Insights
Genetic counseling is crucial for Pompe disease patients and families, offering vital information on inheritance, risks, and treatments. Standardized practices are needed to ensure informed decision-making and comprehensive care for all diagnosed individuals.
Area of Science:
- Medical Genetics
- Rare Diseases
- Genetic Counseling
Background:
- Pompe disease requires coordinated care, with genetic counseling being a key component for all patients.
- Understanding the role and establishing consistent practices for genetic counseling in Pompe disease is currently lacking.
- Genetic counseling aids families in comprehending medical information and making informed decisions regarding Pompe disease management.
Purpose of the Study:
- To provide guidance on genetic counseling for Pompe disease, particularly for those identified through newborn screening (NBS).
- To clarify the role of genetic counseling for families and healthcare teams involved in Pompe disease care.
- To establish a framework for standardized genetic counseling practices for patients and at-risk family members.
Main Methods:
- Expert consensus from the Pompe Disease Newborn Screening Working Group.
- Development of guidance for genetic counseling practices in the context of Pompe disease diagnosis and management.
- Focus on information dissemination regarding inheritance, genetic risks, treatments, and resources.
Main Results:
- The guidance aims to standardize genetic counseling for Pompe disease patients and families.
- It addresses special considerations, including early diagnosis of late-onset Pompe disease and implications of genetic risk assessment.
- The framework supports informed decision-making for patients, carriers, and at-risk relatives.
Conclusions:
- Genetic counseling is essential for comprehensive Pompe disease care, regardless of diagnosis method (NBS, clinical, prenatal).
- Standardized genetic counseling practices are necessary to support patients, families, and healthcare providers.
- This guidance provides a framework to improve understanding and implementation of genetic counseling for Pompe disease.
Abstract:
An important part of the coordinated care by experienced health care teams for all Pompe disease patients, whether diagnosed through newborn screening (NBS), clinical diagnosis, or prenatal diagnosis, is genetic counseling. Genetic counseling helps families better understand medical recommendations and options presented by the patient's health care team so they can make informed decisions. In addition to providing important information about the inheritance and genetic risks, genetic counseling also provides information about Pompe disease and available treatments and resources and should be offered to families with an affected child and all adults diagnosed with Pompe disease. Although the need for genetic counseling after a positive newborn screen for Pompe disease is recognized, the role that genetic counseling plays for both families of affected patients and health care teams is not fully understood. Consistent best genetic counseling practices also are lacking. The guidance in this article in the "Newborn Screening, Diagnosis, and Treatment for Pompe Disease" supplement is derived from expert consensus from the Pompe Disease Newborn Screening Working Group. It is intended to help guide genetic counseling efforts and provide a clear understanding of the role for families or carriers of Pompe disease identified through NBS; explain special considerations (eg, diagnosis of late-onset Pompe disease before the appearance of symptoms) and the impact and implications associated with a diagnosis (eg, determination of genetic risk and carrier status and preconception counseling); and provide health care teams caring for patients with a framework for a standardized approach to genetic counseling for patients and at-risk family members.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pedigree Analysis
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters